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Objectives: HIV is able to continuously adapt to and evade the evolving
neutralizing antibody responses of the host. We investigated the ability of HIV
variants to evade neutralizing antibodies in order to understand the distinct
characteristics of HIV-1 Korean clade B.
Methods: Three drug-naive subjects were enrolled in this study who were
infected with HIV-1 Korean clade B. Neutralizations were performed using
autologous plasma and pseudovirion-based assays in order to analyze and
compare changes in the env gene.
Results: In the early phase of infection, neutralizing activities against autologous
virus variants gradually increased, which was followed by a decline in the
humoral immune response against the subsequent viral escape variants. The
amino acids lengths and number of potential N-linked glycosylation sites (PNGS)
in HIV-1 env gene was positively correlated with neutralized antibody responses
during the early stages of infection.
Conclusion: This study suggests that change within the env domains over the
course of infection influences reactivities to neutralized antibodies and may also
have an impact on host immune responses. This is the first longitudinal study of
HIV-1 humoral immunity that took place over the entire course of HIV-1 Korean
clade B infection.1. Introduction
Within-host HIV-1 evolution is characterized by the
diversification of the infecting virus population after the
time of infection [1]. In addition to genetic drift and
purifying selection, HIV-1 can evolve under positive
selection from antibodies and cytotoxic T lymphocytesibuted under the terms o
y-nc/3.0) which permits unr
is properly cited.
ase Control and Prevention[2]. In this process, neutralizing antibodies are the
principal component required for an effective immune
response to HIV.
HIV-1 envelope glycoprotein (Env) is the primary
viral antigen that is targeted by neutralizing antibodies,
so genetic variation in the env gene of HIV-1 is closely
related to the neutralizing antibody response [3,4].f the Creative Commons Attribution Non-Commercial License
estricted non-commercial use, distribution, and reproduction in
. Published by Elsevier Korea LLC. All rights reserved.
152 B.G. Shin, et alPrevious studies have reported that the development
of Nab responses in the initial phase of HIV-1 infection
[5,6], but there were few reports describing neutraliza-
tion activities over the entire course of HIV evolution in
longitudinally monitored HIV-positive subjects. Also,
the relationship between neutralizing antibodies, HIV-1
genetic variation, and the functional mechanism by
which neutralizing antibodies respond to HIV-1 is not
completely understood. Therefore, in order to under-
stand the evolution of the virus, a longitudinal study on
viral variation and neutralizing antibody responses is
need.
Genetic diversity and divergence in HIV-1 Korean
clade B are much lower than those reported in HIV
strains in other countries [7]. These characteristics of
HIV-1 Korean clade B may support important immu-
nological advantages [8].
The goal of this study is to investigate the relation-
ship between Nab responses and the env gene, which is
the target of neutralization responses in subjects
with Nabs. We also examined sequential neutralization
responses in autologous plasma obtained from patients
infected with HIV-1 Korean clade B.2. Materials and Methods
2.1. Study subjects, cells, and plasma samples
Blood samples taken from patients with a suspected
HIV infection were referred to the Korea Center for
Disease Control (KCDC) from public health centers,
hospitals and local blood banks through local Institutes of
Public Health and Environment (IPHE) for the final HIV
confirmation test. Among these patients, three were
diagnosed with preseroconversion status and could be
monitored longitudinally. None of these subjects received
antiretroviral therapy over the course of this study.
293T/17 and TZM-bl cells were obtained from the
National Institute for Biological Standards and Control
(catalog No. ARP5011) and the American Type Culture
Collection (catalog No. 11268), respectively. An env-
deficient HIV-1 backbone vector (pSG3 Env) was ob-
tained through the NIH AIDS Research and Reference
Reagent Program (catalog No. 11051).
2.2. Cloning of full-length HIV-1 env genes and
pseudovirus production
Genomic DNA was extracted from the peripheral
blood mononuclear cells (PBMCs) using QIAamp DNA
blood mini kits (QIAgen, Valencia, CA, USA). We
amplified a 3.2-kb region of the HIV-1 env gene using
nested polymerase chain reaction (PCR), as previously
described [9].
The purified PCR products were cloned into the
pcDNA3.1/V5-His-Topo vector (Invitrogen Corp.,
Carlsbad, CA, USA). Pseudoviruses were produced by
infecting 293 T cells with the env expression plasmidand pSGDenv vector using the FuGENE 6 transfection
kit (Invitrogen). Pseudovirus-containing culture super-
natants were harvested 72 hours after transfection,
filtered (0.45 mm), and stored at -80 C until use in the
neutralization assays.
2.3. Neutralization assay
The activities of the neutralizing antibodies were
measured as the reduction in b-galactosidase reporter
gene expression after a single round of viral infection in
TZM-bl cells, as previously described [1]. In brief, 100
TCID50 pseudoviruses and heat-inactivated plasma
mixtures were incubated at 37C for 1 hour and then
added to a preparation of TZM-bl cells (1 104 cells/
mL) on 96-well plates. The cells were then harvested
after incubation for 48 hours and counted using
a b-galactosidase-staining V2600 staining kit (Takara
Bio Inc., Tokyo, Japan). The 50% inhibitory concen-
tration (IC50) of the neutralizing antibody was defined as
the concentration of plasma dilution required to decrease
the number of infected cells by 50% at 48 hours after
infection with 100 TCID50, and the IC50 was calculated
from the mean value of the repeated results. Two
independent experiments were performed in duplicate.
2.4. Sequencing and phylogenetic analyses
The sequencing reaction for the env region was
performed using the ABI Prism Dye Terminator Cycle
Sequencing Ready Reaction Kit (Applied Biosystems,
CA, USA) in an automated ABI prism 3730 DNA
sequencer (Perkin Elmer, CT, USA). The nucleotide
and amino acid sequences of the env gene were
aligned using the Lasergene software package
(DNASTAR Inc., WI, USA). Phylogenetic analyses
were performed using PAUP (Phylogenetic Analysis
Using Parsimony, version 4.0; http://paup.csit.fsu.
edu/). The number and position of potential N-linked
glycosylation sites (PNGS) were analyzed using the
N-GlycoSite program (www.hiv.lanl.gov/content/
sequence/GLYCOSITE/glycosite.html). Aligned amino
acid sequences were analyzed using Jalview (www.
jalview.org).
2.5. Statistical analysis
Statistical analyses were performed using SAS version
9.1 (SAS Institute, Inc., Cary, NC, USA). Spearman’s
rank correlation method was used to determine the
significance of any association between the neutralizing
antibody response and the HIV env sequence.3. Results
3.1. Characteristics of study subjects
Three subjects (K1004, K1314, and K2160) with
primary HIV infection (PHI) were selected for moni-
toring over the course of their infections, all of whom
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group was 36.3 years. The average course of infection
after PHI was 4.8 years, and eight time points were
sampled over 85 months (7.1 years) for K1004, six time
points over 63 months (5.3 years) for K1314, and five
time points were sampled over 25 months (2.1 years) for
K2160. The route of transmission for each subject was
sexual contact with men who have sex with men
(MSM). The mean values for the longitudinal samples
were 449 cells/mm3 (range: 147e896 cells/mm3) for
CD4þ T cells and 1,083 cells/mm3 (range: 599e1,954
cells/mm3) for CD8þ T cells (Table 1). Phylogenetic
tree analysis of all HIV-1 env sequences showed that all
isolates were HIV-1 Korean clade B (Figure 1).
3.2. Viral escape pattern of neutralization
against autologous viruses over the course
of evolution
Pseudoviruses were produced from each individual in
order to analyze neutralization reactivity. We deter-
mined the neutralization reactivity against autologous
HIV-1 env pseudovirus at each sampled time point in
order to analyze cross-reactivity at different stages of
evolution.
In the evaluations of the neutralizing activities to
HIV-1 plasma at different stages, the pseudoviruses that
were produced in the early phase showed low neutral-
izing reactivities to contemporaneous plasma compared
with the later phase, which was significant except for
K2160 (p< 0.005). In K1004 and K1314, gradual
increases were observed after early phase, but theseTable 1. Epidemiological and immunological characteristics of
Subjects Number
Time
interval* (mo)
K1004 (diagnosed in Jan 2001) 1 1
2 14
3 26
4 38
5 58
6 65
7 72
8 86
K1314 (diagnosed in Dec 2001) 1 1
2 20
3 29
4 36
5 46
6 64
K2160 (diagnosed in Jun 2002) 1 18
2 25
3 31
4 37
5 44
mean
*Time interval from initial diagnosis with HIV-1.
ND, not determined.increased neutralization activities were reduced by 4
years post-HIV infection. K2160, who was monitored
for relatively shorter time than the other subjects,
showed a gradually increase in neutralization activities
that was time dependent (Figure 2). Specifically, K1004,
who produced by eight samples at each time point,
showed the most complicated neutralization pattern
which also showed reversion. There was an increase in
the neutralization pattern in the early phase through the
fourth time point, but this increase began to decrease
through measurement at the seventh time point. In case
of K1314, the results show an increased pattern from the
first through the fifth time point and reduced neutrali-
zation by the last time point, similar to K1004.
However, for K2160, who provided five samples at each
time point, we were unable to determine the escape
pattern in the later phase; only a steadily rising
neutralization pattern was identified in the early phase.
3.3. Genetic variation of env gp160 over the
course of evolution
Genetic variations mainly existed in gp120 as result
of insertions and deletions in this region. In K1004, most
PNGS variations were observed in all variable loops
over the course of infection, but some changes in the
lengths of various amino acids could only be observed at
V4 region (Table 2). In K1314, the lengths of the amino
acids and PNGS were changed in all regions except V3.
Specifically, the lengths of the amino acids over the
course of infection showed a decrease in V1, V4, and
V5, and the number of PNGS also decreased in V1 andKorean subjects infected with HIV-1 type B
Sampling
date
CD4þ T cell
(cells/mm3)
CD8þ T cell
(cells/mm3)
Viral Load
(copies/mL)
Feb 2001 450 1407 17,962
Mar 2002 440 886 4394
Mar 2003 470 1027 6745
Mar 2004 415 1756 188
Oct 2005 743 1909 6008
May 2006 725 1597 131
Dec 2006 896 1954 116
Feb 2008 873 1760 369
Jan 2002 153 969 170,669
Jul 2003 186 599 11,862
Apr 2004 236 788 4,966
Nov 2004 150 699 5000
Sep 2005 129 675 6008
Mar 2007 147 728 510,228
Nov 2003 578 1194 404
Jun 2004 587 797 ND
Dec 2004 404 564 101
Jun 2005 478 665 ND
Dec 2005 471 603 ND
449 1083 39,218
Figure 1. Phylogenetic relationships between HIV-1 env (gp120) sequences of Korean subjects infected by HIV-1 Korean clade
B and env sequences of 17 different type B reference strains from the HIV database in Los Alamos National Laboratory (http://
www.hiv.lanl.gov). This phylogenetic tree was constructed using the neighbor-joining method used by the PAUP* 4.10b program.
The numbers at the nodes represent the bootstrap values calculated from 1000 bootstrap resamplings. The three infected Korean
patients are labeled from according to the sampling time.
154 B.G. Shin, et alV4. In K2160, variations in the lengths of amino acids
were observed only at V1 and V5, but the number of
PNGS changed in all regions except V3.
In the analysis of the CD4- and CCR5-binding sites,
most amino acids were conserved in those sites, but
some changes were observed over the course of infec-
tion and the changes observed at each time point were
different for each individual. Regarding changes in the
CD4-binding site, D474 N was noted in subject K1004
and N279D, T283 N, and D474 N were noted in subject
K1314. Regarding changes in CCR5-binding site,
F317L and R440 K were noted in subject K1004, and
changes in K440R were noted in subject K1314.
However, no changes were observed in subject K2160
(data not shown).3.4. Relationship between env sequence and
neutralization reactivities
The results of the analysis between variations in env
genes and neutralization titers (IC50) showed that the
lengths of the amino acids in regions V1eV5 had
a significant but weakly positive correlation with the
neutralization titers (rZ 0.279, pZ 0.026) in subject
K1004. Also, the number of PNGS in same region was
positively correlated with the neutralization titers
(rZ 0.349, pZ 0.005). However, in the case of subject
K1314, the lengths of the amino acids and the number of
PNGS were weakly and positively correlated with the
neutralization titers, but this finding was not significant.
Also, correlation analysis of subject K2160 showed results
that were similar to those of subject K1314 (Figure 3).
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Figure 2. Autologous cross-reactivity of HIV-1 pseudovi-
ruses against neutralizing antibodies in Korean HIV-1 longi-
tudinal subjects over the course of HIV-1 infection. PV,
pseudovirus.
Table 2. Comparison of amino acids lengths and number of PN
Subject
Sampling
interval (mo)
Length of amino acids
V1-V2 V3 V4 V5 gp120 gp
K1004 - 75 35 30 12 387 34
13 75 35 30 12 387 34
25 75 35 30 12 387 34
37 75 35 29 12 386 34
57 75 35 29 12 386 34
64 75 35 29 12 386 34
71 75 35 30 12 387 34
85 75 35 30 12 387 34
Mean 75 35 29.6 12 386.6 34
K1314 - 76 35 35 13 394 34
19 76 35 35 13 394 34
28 76 35 34 9 389 34
35 74 35 33 9 386 34
45 76 35 34 9 389 34
63 72 34 31 8 379 34
Mean 75 34.8 33.7 10.2 388.5 34
K2160 - 69 35 31 9 380 34
7 65 35 31 9 376 34
13 65 35 31 11 378 34
19 65 35 31 8 375 34
25 65 35 31 9 375 34
Mean 65.8 35 31 9.2 376.8 34
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This study was designed to investigate the mecha-
nism used by HIV-1 Korean clade B to escape humoral
immune responses.
In order to respond to the HIV virus, broadly reactive
neutralization responses against the virus must be
developed in order to design an effective HIV-1 vaccine.
Therefore, it is important to investigate the genetic
characteristics of predominant HIV strains in each
country and understand the subsequent immune mech-
anisms involved in the neutralizing antibody responses.
As previously reported, the expansion of genetic
variations in HIV-1 infected Korean subjects is much
lower than that reported in other countries [7]. Also, the
neutralizing antibody responses to HIV-1 Korean clade
B show broad reactivity to HIV-1 subtype B [8]. In order
to develop effective, region-specific vaccines, under-
standing the limited genetic characteristics of Korean
clade B might be advantageous to understanding how
HIV elicits humoral immune responses.
In this study, all subjects developed neutralizing
antibody responses against their sequential autologous
plasma. Within most time points, titers against an earlier
virus were greater than against contemporaneous or later
viruses, indicating changes in immune pressure and viral
escape.
Similar to other observations [1,4,10], two of the
three subjects showed a decline in autologous neutrali-
zation during chronic infection as a result of both viralGS in HIV-1 env gp160 in Korean HIV-1 subjects
No. of potential N-linked glycosylation sites
41 V1-V2 V3 V4 V5 gp120 gp41
5 8 2 4 2 27 5
5 8 2 4 2 27 5
5 7 1 5 1 25 5
5 7 1 4 2 24 4
5 8 1 4 1 24 5
5 7 1 4 1 23 5
5 7 1 5 1 24 5
5 7 1 5 2 25 5
5 7.4 1.2 4.4 1.5 24.9 4.9
5 7 1 6 2 27 5
5 7 1 6 2 27 5
5 7 1 4 2 24 5
5 7 1 5 2 25 5
5 7 1 5 1 24 5
5 5 1 5 2 23 5
5 6.7 1 5.2 1.8 25 5
5 7 1 4 1 24 5
5 6 1 4 1 24 5
5 6 1 4 1 24 5
5 6 1 4 0 24 4
5 6 1 4 1 23 5
5 6.2 1 4 0.8 23.8 4.8
Figure 3. Correlation between amino acid length and PNGS number in the V1eV5 regions of HIV-1-infected Korean subjects
and the total reactivity against neutralizing antibodies. (A) K1004, (B) K1314, (C) K2160.
156 B.G. Shin, et alescape and the limited ability of the immune response
against viral escape variants. Thus, the loss of neutral-
ization by sequential viruses over time suggests that
some viruses could evolve to escape the effects of
a potent vaccine, and vaccines must target the envelope
regions that are less likely to evolve and escape recog-
nition by vaccine-induced antibodies [4].
Other studies have shown that HIV-1 sequences that
have been isolated during chronic infection have
significantly longer V1-V2 loops and a significantly
higher number of PNGS sites than sequences that are
isolated during the early phases of infection [11,12].
These studies suggest that changes within the V1-V2envelope domains over the course of an infection
influences sensitivity to autologous neutralizing anti-
bodies and may also have an impact on host interactions.
However, we observed a decrease in the lengths of the
variable loops and in the number of PNGS in gp120 that
were irrespective of the detected autologous neutralizing
activities in plasma. Also, PNGS analysis demonstrated
only a small amount of variation, but in a subject-
specific way, suggesting that these variations are not
confined to the variable regions of gp120 and can also be
observed in constant regions.
In our study, Nab responses did not correlate with env
variation during chronic infection. The absence of an
Neutralizing antibody escape of HIV-1 Korean clade B 157absolutely temporal relationship between the dynamics
of the length and level of glycosylation of env indicate
that the influence of the selection processes on Env
characteristics may be caused by various factors. Espe-
cially, the escape pattern from neutralizing antibody
responses may occur through a combination of point
mutations (i.e., substitution of amino acids), changes in
glycosylation patterns, and insertions and deletions in
the viral envelope [13]. This suggests that the Nab
response is not a dominant, selective force on env
evolution.
Additionally, these characteristics of HIV is based on
many complicated mechanisms and factors, such as the
high diversity of HIV and the structural features that
determine T cell accessibility and glycosylation that
might affect the HIV-neutralization epitope; therefore,
HIV evolution should be considered when studying
HIV neutralization. One study on HIV subtype C [12]
showed that the escape pattern of HIV might be influ-
enced by immune responses to different regions and
that the HIV neutralization process requires multiple
pathways.
In conclusion, this is the first report on neutralizing
humoral immune responses against HIV-1 Korean
clade B and viral escape that take into account the
molecular changes in the viral envelope that take place
over the entire course of infection. HIV-1 Korean clade
B viruses can evolve over time to become resistant or
sensitive to the effects of antibodies, so the changes in
Env should be carefully considered when attempting to
design a potent vaccine against HIV-1 Korean clade B.
This information may be useful for developing an
AIDS vaccine and therapies against HIV-1 Korean
clade B.Acknowledgements
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